Page last updated: 2024-11-02

pentobarbital and Migraine Disorders

pentobarbital has been researched along with Migraine Disorders in 3 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RYAN, RE1
MacNeal, PS1
McLeod, RL1
Aslanian, R1
del Prado, M1
Duffy, R1
Egan, RW1
Kreutner, W1
McQuade, R1
Hey, JA1

Other Studies

3 other studies available for pentobarbital and Migraine Disorders

ArticleYear
Pentergot inserts for the symptomatic treatment of migraine.
    Headache, 1961, Volume: 1

    Topics: Atropa belladonna; Caffeine; Ergot Alkaloids; Migraine Disorders; Pentobarbital

1961
The patient with headache.
    Postgraduate medicine, 1967, Volume: 42, Issue:4

    Topics: Age Factors; Alkaloids; Atropa belladonna; Caffeine; Diagnosis, Differential; Ergotamine; Headache;

1967
Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:1

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Elec

1998